
Keywords: urinary bladder; urinary incontinence; stress; myoblasts; chemokine CXCL12; cell- and tissue-based therapy; CXCR4; chemokine receptor type 4; DMEM; Dulbecco's modified Eagle's medium; ISD; intrinsic urinary sphincter deficiency; MSC; mesenchymal stem